Skip to main content
Premium Trial:

Request an Annual Quote

HiberGene Licenses LAMP Tech from Eiken Chemical

NEW YORK (GenomeWeb) — HiberGene Diagnostics said today that it has secured a non-exclusive license to use Eiken Chemical's loop-mediated isothermal amplification (LAMP) technology.

Specifically, Dublin-based HiberGene gains the rights to develop, manufacture, and market diagnostic products for human infectious diseases using LAMP in exchange for an undisclosed license fee and royalty payments.

HiberGene used the LAMP technology to develop its first two products, molecular tests for meningitis and Group B Streptococcus. Both tests are highly accurate and rapid, producing positive results in less than 10 minutes, which makes them ideal for use in a range of clinical and patient care environments.

"With this license now secured, we can begin manufacturing and marketing our meningitis and Group B Streptococcus products while also developing a range of other tests for human infectious diseases," HiberGene Executive Chairman Brendan Farrell said in a statement.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.